Valeo Financial Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-7,449
Closed -$260K 609
2022
Q1
$260K Sell
7,449
-6,730
-47% -$230K 0.01% 479
2021
Q4
$432K Sell
14,179
-9,109
-39% -$297K 0.02% 341
2021
Q3
$764K Buy
23,288
+1,823
+8% +$58.3K 0.04% 222
2021
Q2
$650K Buy
+21,465
New +$707K 0.04% 220

Other funds holding OGN

Valeo Financial Advisors's OGN Position: Q2 2022 in Review

Valeo Financial Advisors sold out of Organon & Co (OGN) in Q2 2022, closing a stake of 7,449 shares — an estimated $260K sold.

Valeo Financial Advisors first reported a position in OGN in Q2 2021 and held it in 4 quarters. The position peaked at $764K in Q3 2021. 853 funds tracked by Wall St. Rank hold OGN as of Q2 2022.

  • Valeo Financial Advisors reported no remaining Organon & Co position as of Q2 2022 after selling out during the quarter.
  • Valeo Financial Advisors sold 7,449 Organon & Co shares in Q2 2022, an estimated $260K.
  • Valeo Financial Advisors first reported a position in Organon & Co in Q2 2021 and held it in 4 quarters.
  • Valeo Financial Advisors's Organon & Co position peaked at $764K in Q3 2021.
  • 853 funds tracked by Wall St. Rank held Organon & Co as of Q2 2022.

Based on Valeo Financial Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.